Yi-Hui Bi
Overview
Explore the profile of Yi-Hui Bi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
57
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bu F, Jia P, Zhu Y, Yang Y, Meng H, Bi Y, et al.
Mol Ther Methods Clin Dev
. 2022 Jul;
26:191-206.
PMID: 35859692
Liver fibrosis is a wound-healing response that results from various chronic damages. If the causes of damage are not removed or effective treatments are not given in a timely manner,...
2.
Wang L, You H, Meng H, Pan X, Chen X, Bi Y, et al.
J Cell Physiol
. 2021 Oct;
237(2):1471-1485.
PMID: 34698390
Alcohol metabolism causes hepatocytes to release damage-associated molecular patterns (DAMPs). This includes mitochondrial DNA (mtDNA), which is generated and released from damaged hepatocytes and contributes to liver injury by producing...
3.
Wang G, Zhong W, Bi Y, Tao S, Zhu H, Zhu H, et al.
Cancer Manag Res
. 2019 Dec;
11:9685-9699.
PMID: 31814764
Purpose: PRDX (Peroxiredoxin) family has involved in breast cancer tumorigenesis from the evidence obtained from cell lines, human tissues and mouse models. Nonetheless, the diversified expression patterns, coupled with the...
4.
Pan X, You H, Wang L, Bi Y, Yang Y, Meng H, et al.
Theranostics
. 2019 Jul;
9(15):4308-4323.
PMID: 31285763
: Liver fibrosis is characterized by extensive deposition of extracellular matrix (ECM) components in the liver. RCAN1 (regulator of calcineurin 1), an endogenous inhibitor of calcineurin (CaN), is required for...